Baculoviruses as gene therapy vectors for human prostate cancer

TY - JOUR

T1 - Baculoviruses as gene therapy vectors for human prostate cancer

AU - Rivera-Gonzalez, Guillermo C

AU - Swift, Stephanie L

AU - Dussupt, Vincent

AU - Georgopoulos, Lindsay J

AU - Maitland, Norman J

N1 - Copyright © 2011 Elsevier Inc. All rights reserved.

PY - 2011/7

Y1 - 2011/7

N2 - Prostate cancer is the most commonly diagnosed cancer in ageing men in the western world. While the primary cancers can be treated with androgen ablation, radiotherapy and surgery, recurrent castration resistant cancers have an extremely poor prognosis, hence promoting research that could lead to a better treatment. Targeted therapeutic gene therapy may provide an attractive option for these patients. By exploiting the natural ability of viruses to target and transfer their genes into cancer cells, either naturally or after genetic manipulation, new generations of biological control can be developed. In this review we present the advantages and practicalities of using baculovirus as a vector for prostate cancer gene therapy and provide evidence for the potential of the baculovirus Autographa californica multiple nucleopolyhedrovirus (AcMNPV) as a safer alternative vehicle for targeting cancer cells. Strategies to target baculovirus binding specifically to prostate cell surfaces are also presented. The large insertion capacity of baculoviruses also permits restricted, prostate-specific gene expression of therapeutic genes by cloning extended human transcriptional control sequences into the baculovirus genome.

AB - Prostate cancer is the most commonly diagnosed cancer in ageing men in the western world. While the primary cancers can be treated with androgen ablation, radiotherapy and surgery, recurrent castration resistant cancers have an extremely poor prognosis, hence promoting research that could lead to a better treatment. Targeted therapeutic gene therapy may provide an attractive option for these patients. By exploiting the natural ability of viruses to target and transfer their genes into cancer cells, either naturally or after genetic manipulation, new generations of biological control can be developed. In this review we present the advantages and practicalities of using baculovirus as a vector for prostate cancer gene therapy and provide evidence for the potential of the baculovirus Autographa californica multiple nucleopolyhedrovirus (AcMNPV) as a safer alternative vehicle for targeting cancer cells. Strategies to target baculovirus binding specifically to prostate cell surfaces are also presented. The large insertion capacity of baculoviruses also permits restricted, prostate-specific gene expression of therapeutic genes by cloning extended human transcriptional control sequences into the baculovirus genome.

UR - http://www.scopus.com/inward/record.url?scp=79960629008&partnerID=8YFLogxK

U2 - 10.1016/j.jip.2011.05.006

DO - 10.1016/j.jip.2011.05.006

M3 - Article

C2 - 21784232

SN - 1096-0805

VL - 107 Suppl

SP - S59-70

JO - Journal of invertebrate pathology

JF - Journal of invertebrate pathology

IS - SUPPL.

ER -